Since Jan started in the pharmaceutical industry in the early 1990s, he has held various commercial positions in small and large companies, both in Norway and in the Nordic Region. Since the beginning of 2000, Jan's focus has been in the field of orphan/ultraorphan disease and he's been involved/responsible for starting up Norwegian/Nordic commercial operations in several companies, latest Alnylam Pharmaceuticals
Email - jan.westerblad@rudpedersen.com
Telephone - +47 4840 1490
2017 - 2022: General Manager, Nordic Region, Alnylam Pharmaceuticals, Stockholm, Sweden
2015 - 2017: Country Manager, Nordic Region, Vertex Pharmaceuticals, Stockholm, Sweden
2012 - 2015: Country Manager, Nordic Region, Aegerion Pharmaceuticals, Oslo, Norway
2002 - 2012: Area Manager, Nordic Business Unit Manager, Country Manager, Genzyme, Oslo/Copenhagen, Norway/Denmark
2000 - 2002: Product Group Manager, Swedish Orphan A/S, Oslo, Norway
2007: Financial Leadership, Genzyme, Cambridge, USA
2005: Leadership Development, Center for Creative Leadership, Greensboro, USA
1990: Bachelor of Science, University of Cincinnati, USA